| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |